Prospective Safety and Feasibility trial of Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma (mRCC)

被引：0
|
作者：
All, S. [1 ]
de Leon, A. Diaz [2 ]
Mohamad, O. [3 ]
Choy, H. [4 ]
Hammers, H. [5 ]
Sanjeevaiah, A. [6 ]
Arafat, W. [6 ]
Courtney, K. [5 ]
Timmerman, R. D. [4 ]
Brugarolas, J. [7 ]
Hannan, R. [4 ]
机构：
[1] UT Southwestern, Dept Radiat Oncol, Dallas, TX USA
[2] UT Southwestern, Dept Radiol, Dallas, TX USA
[3] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA
[5] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[6] UT Southwestern, Dept Hematol Oncol, Dallas, TX USA
[7] Univ Texas Southwestern Med Ctr Dallas, Dept Hematol Oncol, Dallas, TX 75390 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4086
引用
收藏
页码：E896 / E897
页数：2
相关论文
共 50 条
  • [21] NRG-GU012: randomized phase II stereotactic ablative radiation therapy (SABR) for metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI)
    McKay, Rana
    ONCOLOGIST, 2023, 28
  • [22] NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI)
    Hall, William A.
    Karrison, Theodore
    McGregor, Bradley Alexander
    Barata, Pedro C.
    Nagar, Himanshu
    Tang, Chad
    Siva, Shankar
    Morgan, Todd Matthew
    Lang, Joshua Michael
    Glide-Hurst, Carri
    Kamran, Sophia C.
    Sundaram, Karthik
    Katz, Sharyn I.
    Feng, Felix Y.
    Mckay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Renal safety of sunitinib treatment: A prospective study for patients (pts) with metastatic renal cell carcinoma (mRCC)
    Billemont, B.
    Rixe, O.
    Meric, J. B.
    Alexandre, J.
    Goldwasser, F.
    Izzedine, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 36 - 36
  • [24] Phase II trial of high-dose interleukin-2 (IL-2) and stereotactic radiation therapy (SABR) for metastatic clear cell renal cell carcinoma (ccRCC): Interim analysis.
    Hannan, Raquibul
    Ishihara, Dan
    Louder, Kristi
    Ahn, Chul
    Margulis, Vitaly
    Arriaga, Yull Edwin
    Courtney, Kevin Dale
    Timmerman, Robert D.
    Brugarolas, James
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [25] Mid -Term Analysis of the Combination Therapy of Axitinib, Toripalimab, and Stereotactic Ablative Body Radiotherapy (SABR) in the Treatment of Recurrent Metastatic Renal Cell Carcinoma
    Hu, K.
    Ma, M. W.
    Gao, X. S.
    Chen, J. Y.
    Li, X. Y.
    Qin, S. B.
    Ren, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E538 - E538
  • [26] The emerging roles of stereotactic ablative radiotherapy for metastatic renal cell carcinoma
    Cheung, Patrick
    Thibault, Isabelle
    Bjamason, Georg A.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2014, 8 (03) : 258 - 264
  • [27] Looking for predictive biomarkers for sunitinib in metastatic renal clear cell carcinoma (mRCC)
    Maroto, P.
    Esteban, E.
    Méndez-Vidal, M. J.
    Fernandez-Parra, E. M.
    Leon, L.
    Perez-Valderrama, B.
    Domenech, M.
    Calderero, V.
    Perez-Gracia, J. L.
    Algaba, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S676 - S676
  • [28] Presurgical sunitinib in primary metastatic renal cell carcinoma (mRCC) - Interim analysis of a prospective trial
    Bex, A.
    Blank, C.
    Horenblas, S.
    Haanen, J.
    BJU INTERNATIONAL, 2010, 105 : 10 - 11
  • [29] Pseudoprogression: A case of metastatic renal clear cell carcinoma treated with nivolumab
    Tabei, Tadashi
    Tsuura, Yukio
    Kobayashi, Kazuki
    PATHOLOGY INTERNATIONAL, 2018, 68 (11) : 627 - 629
  • [30] TOLERABILITY OF STEREOTACTIC ABLATIVE BODY RADIOTHERAPY (SABR) FOR PRIMARY RENAL CELL CARCINOMA: PRELIMINARY ANALYSIS OF THE FASTRACK CLINICAL TRIAL
    Siva, S.
    Jackson, P.
    Brook, N.
    Grills, R.
    Moon, D.
    Lawrentschuk, N.
    Goad, J.
    Kron, T.
    Gill, S.
    Chander, S.
    Tai, K.
    Shaw, M.
    Pham, D.
    Foroudi, F.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 26 - 27
12345